Treatment for childhood rhabdomyosarcoma: the cost of cure.
about
The surgical management of paediatric bladder and prostate rhabdomyosarcomaGlobal gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomasManagement of pediatric head and neck rhabdomyosarcoma: A case-series of 36 patientsSparing strategy does not compromise prognosis in pediatric localized synovial sarcoma: experience of the International Society of Pediatric Oncology, Malignant Mesenchymal Tumors (SIOP-MMT) Working Group.MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas.Gene expression profiling for survival prediction in pediatric rhabdomyosarcomas: a report from the children's oncology group.Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology GroupDelayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.Higher rates of metastatic disease may explain the declining trend in Swedish paediatric rhabdomyosarcoma survival rates.Role of surgery in the management of soft tissue tumors.Imaging findings in noncraniofacial childhood rhabdomyosarcoma.Prognostic Factors for Outcome in Localized Extremity Rhabdomyosarcoma. Pooled Analysis from Four International Cooperative Groups.Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo.Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment.Credentialing a preclinical mouse model of alveolar rhabdomyosarcoma.Selecting multimodal therapy for rhabdomyosarcoma.Pharmacotherapy for pediatric soft-tissue sarcomas.Optimal surgical treatment and urological outcomes in boys with pelvic and urogenital rhabdomyosarcomas and soft tissue sarcomas.Identification of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma.Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells.Hearing loss in survivors of childhood head and neck rhabdomyosarcoma: a long-term follow-up study.Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second-line chemotherapy.Conservative management of primary vaginal endodermal sinus tumor and rhabdomyosarcoma.Brachytherapy in children with rhabdomyosarcomas of the nasolabial fold.CSPG4: A Target for Selective Delivery of Human Cytolytic Fusion Proteins and TRAIL.Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International SocietConservative approach in localised rhabdomyosarcoma of the bladder and prostate: results from International Society of Paediatric Oncology (SIOP) studies: malignant mesenchymal tumour (MMT) 84, 89 and 95.Reconstructive option after radical mutilating surgery in children with genitourinary rhabdomyosarcoma: When sparing the bladder is not an option.Donor lymphocyte infusions in adolescents and young adults for control of advanced pediatric sarcoma.Papular and Nodular Skin Lesions in Children.Prognostic factors for postoperative survival among patients with rhabdomyosarcoma of the limbs
P2860
Q27015190-06866382-0720-4539-9C8E-85B303DE1EDBQ28300128-2078D4F3-B7C0-484C-AD2C-1E376189B88EQ30369053-A8FF668F-8662-4821-AE45-3E2979F43B65Q33873982-4650B8BB-764F-49E9-A949-82D64B4A191AQ33906031-89940432-2109-430A-A1D9-6B5AFC84A504Q34578460-8722BEB0-C867-42A7-85C8-3B45686A4DC5Q35207522-35949FBA-0754-45FA-BB8A-2B4EAB9723FAQ35760674-21FA8B44-72E7-4B43-AF19-55B916048478Q36536619-60A93512-C466-49EE-B7C3-B39FB2E6E8ADQ36616534-DC2C4AB7-207D-4A6C-AC3E-72C06ADF1738Q36632585-A0E95929-E2D1-47BE-8948-951E634B0EABQ37212341-FE60434F-2F74-4B6A-97A2-D45993BCEF45Q37281508-1257FCD0-1CFD-4E16-B5CE-1092B16DD187Q37323038-0BA10EC3-9216-44A5-AD7E-2246EF847C98Q37463146-3193D151-3B8B-4145-B05C-03678D26E38FQ37782096-71D97156-AA7C-4DB8-A9AD-B590CB655444Q37838445-251FA26B-8491-4E5B-9C31-9768569EF63BQ38132620-E9AD59EC-A043-40C1-A3DD-E9918295918DQ38489532-FEA9E751-7E1D-44AC-945E-7C028574A6CBQ38855577-3C59CA92-C444-41CF-9C97-EC9D243F8EC5Q41465765-ED013FBD-EF1E-40BD-8483-A2468FD5C2E9Q41607004-65BA2700-CE49-4776-A9F9-A8ADA225EC91Q41808313-516B059A-91E8-4B04-B597-FC9064C6AFF9Q45152632-1FB59E10-A849-4D11-9BBF-D3D0E0E08220Q50918966-E140C528-D90E-44A0-8724-36A155506712Q51697406-BDD44883-E507-4AF7-B7F7-A6740335C40BQ51787493-3E5DA1C7-A3BE-44C8-B002-415ECCE1DD9DQ54377516-4CC2ABE8-94CA-40A7-84E1-82ECB3B96746Q54977284-A0CCE5FE-05FC-45E1-9784-B65107FDC222Q55539873-4AFF3142-549D-4E9B-874D-7F57BD200398Q57484411-CB6222E5-4A95-4DF6-9BE3-9C4AAAB8C954
P2860
Treatment for childhood rhabdomyosarcoma: the cost of cure.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Treatment for childhood rhabdomyosarcoma: the cost of cure.
@ast
Treatment for childhood rhabdomyosarcoma: the cost of cure.
@en
type
label
Treatment for childhood rhabdomyosarcoma: the cost of cure.
@ast
Treatment for childhood rhabdomyosarcoma: the cost of cure.
@en
prefLabel
Treatment for childhood rhabdomyosarcoma: the cost of cure.
@ast
Treatment for childhood rhabdomyosarcoma: the cost of cure.
@en
P1433
P1476
Treatment for childhood rhabdomyosarcoma: the cost of cure
@en
P2093
Michael C G Stevens
P356
10.1016/S1470-2045(05)01733-X
P577
2005-02-01T00:00:00Z